Navigation Links
Optogenetic tool elucidated
Date:2/28/2012

Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision. The key tool of optogenetics is the light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin have now succeeded in explaining the switching mechanism through an interdisciplinary approach. The researchers report on their findings in the Journal of Biological Chemistry.

Redistribution of water molecules

Until now, little has been known about the mechanism of the protein - especially about how the channel opens. However, deeper understanding is a prerequisite in order to be able to use the light-controlled protein specifically for neurobiological applications. In a new, multi-disciplinary approach, the Bochum scientists led by Prof. Dr. Klaus Gerwert (Department of Biophysics at the RUB) and their cooperation partners in Berlin have been able to shed light on the switching mechanism. The result: the light-induced change in the charge state of amino acid glutamate 90 (E90) triggers an increased penetration of water molecules, so that the protein can now purposefully conduct ions through the cell membrane.

Three methods combined

Using time-resolved infrared spectroscopy, the RUB biophysicists Jens Kuhne and Dr. Erik Freier have been able to show for the first time that the channel is opened through the deprotonation of the amino acid glutamate 90 (E90). In addition, the electrophysiological experiments of the researchers in Berlin confirm that a mutation of the amino acid leads to a change in the ion permeability of the protein. Instead of using safety goggles and lab coats, the two biophysicists Kirstin Eisenhauer and Dr. Steffen Wolf at the Department of Biophysics used supercomputers to simulate how the protonation change of the glutamate opens the channel and allows water molecules to penetrate.

Internationally preeminent

The work has attained particular distinction right now, because shortly after the Bochum pre-publication on the Internet, Japanese researchers published the three-dimensional structure of a channelrhodopsin online in "Nature". "The structure work impressively confirms our biomolecular simulations and the key role played by the amino acid E90 in the switching of the channel", says Prof. Klaus Gerwert. "We are therefore particularly proud to have been preeminent in this internationally competitive field." In 2010, optogenetics was distinguished by "Nature Methods" as the "Method of the Year". Using this method, researchers have succeeded, for example, in restoring the eyesight of blind mice.


'/>"/>

Contact: Dr. Klaus Gerwert
gerwert@bph.rub.de
49-234-322-4461
Ruhr-University Bochum
Source:Eurekalert

Related biology news :

1. Light workout: Stanford scientists use optogenetics to effectively stimulate muscle movement in mice
2. The leading edge of stress: New genomic, optogenetic and epigenetic findings
3. Connection elucidated between obesity, salt sensitivity and high blood pressure
4. A new signaling pathway of the immune system is elucidated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/7/2016)... -- BioCatch , the global leader in behavioral biometrics, ... grew to over 40 granted and pending patents. ... , , The Company,s IP ... System, Device, and Method Estimating Force Applied to a Touch Surface, ... costly hardware components needed to estimate the force and pressure applied to ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium ... announced the appointment of new CEO James ... executive with decades of experience, has served in ... Cisco, where he specialized in expanding a pipeline ... technology portfolios. He most recently served as managing ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 2017 AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: ... aquaculture and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... the listing of its common shares on the NASDAQ ... "AquaBounty,s listing on NASDAQ represents an important ... to the U.S. markets as we advance plans for ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical ... spectrum of drug and device development, and Prism Clinical Research , a ... today announced Verified Clinical Trials (VCT) has been selected by both ...
(Date:1/19/2017)... N.J. , Jan. 18, 2017 BD (Becton, Dickinson ... company, announced today that it will host a live webcast of ... 1 p.m. (ET). The webcast can be accessed ... available for replay through Tuesday, January 31, 2017. ... About BD BD is ...
(Date:1/18/2017)... Applied BioMath ( www.appliedbiomath.com ), the ... and development, today announced that Dr. John ... Applied BioMath, will present at the next Boston ... on Thursday January 19, 2017 at the Broad ... Dr. Burke,s talk "Quantitative Modeling and Simulation Approaches: ...
Breaking Biology Technology: